Table III. Results of the validation of miRNA candidates by qPCR in the extended cohort of rectal cancer patients.
Log2FC: Logarithm to the base 2 of fold change; *qPCR validation of miRNA differences between group of non-responders (TRG 3+4+5) and responders to neoadjuvant chemoradiotherapy (TRG 1+2); **qPCR validation of miRNA differences between group of non-responders (TRG 4+5) and responders to neoadjuvant chemoradiotherapy (TRG 1+2).